Dexrazoxane Intravenous and Hyaluronidase and trastuzumab
Determining the interaction of Dexrazoxane Intravenous and Hyaluronidase and trastuzumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Trastuzumab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Hyaluronidase injection
- Dexrazoxane Intravenous-Hyaluronidase Injection (Human)
- Dexrazoxane Intravenous-Hyaluronidase Subcutaneous, Injection
- Dexrazoxane Intravenous-Hyate:C
- Dexrazoxane Intravenous-Hybrisil
- Dexrazoxane Intravenous-Hycamtin
- Hyaluronidase and trastuzumab-Dextenza Insert
- Hyaluronidase and trastuzumab-Dextenza intraocular
- Hyaluronidase and trastuzumab-Dextran 40
- Hyaluronidase and trastuzumab-Dextran 70 6% in 5% Dextrose high molecular weight
- Hyaluronidase and trastuzumab-Dextran 75
- Hyaluronidase and trastuzumab-Dextran high molecular weight